
Aptevo Therapeutics Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 1 trade in Aptevo Therapeutics Inc (NASDAQ: APVO) since 2019, across 1 member, worth an estimated $500.50 in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). Democratic members are responsible for 100% of the trades and Republican members 0%. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Aptevo Therapeutics Inc (APVO) stock overview and the complete trade table below.
Price & congressional trade timeline
Party breakdown
Aptevo Therapeutics congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
| No congressional trades in this period. | |||||||
Aptevo Therapeutics (APVO) congressional trading FAQ
Can members of Congress legally trade Aptevo Therapeutics (APVO) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Aptevo Therapeutics (APVO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Aptevo Therapeutics (APVO) trades public?
Yes. Every congressional trade in Aptevo Therapeutics (APVO) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Aptevo Therapeutics (APVO)?
Members of Congress have disclosed 1 trades in Aptevo Therapeutics (APVO) worth $500.50 across 1 members, according to public STOCK Act filings.
Do Democrats or Republicans trade Aptevo Therapeutics (APVO) more?
Across disclosed Aptevo Therapeutics (APVO) trades, 100% were by Democrats and 0% by Republicans, led by Democrats (100%).
Browse all stocks Congress tradesCongressional trading overviewAptevo Therapeutics (APVO) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.